• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    In this photo from Feb. 24, Department of Health and Human Services Secretary Alex Azar speaks in Washington, D.C. So far, Azar and the Trump administration want to leverage greater competition in the pharmaceutical market to entice lower prices. (AP Photo/Jose Luis Magana)
    Healthcare

    Trump’s drug-price crackdown misses the mark, experts say

    Robert King -
    March 13, 2018 5:01 am
    0
    House Energy and Commerce Committee Chairman Rep. Greg Walden, R-Ore., (pictured) and Rep. Michael Burgess, R-Texas, have unveiled a right-to-try bill in the House of Representatives on Saturday morning. (AP Photo/J. Scott Applewhite)
    Healthcare

    House panel unveils right-to-try bill

    Robert King -
    March 10, 2018 3:11 pm
    0
    Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, has been found guilty of wire fraud and securities fraud. (AP Photo/Craig Ruttle)
    Beltway Confidential

    The ‘Pharma Bro’ is a cautionary tale

    Becket Adams -
    March 10, 2018 5:01 am
    0
    Martin Shkreli gained notoriety when his company Turing Pharmaceuticals raised the price of the anti-malarial drug Daraprim from $13.50 a pill to $750. (AP Photo/Susan Walsh)
    Healthcare

    ‘Pharma bro’ Martin Shkreli sentenced to 7 years in prison

    Robert King -
    March 9, 2018 7:00 pm
    0
    U-God from the hip-hop group Wu-Tang Clan had choice words for convicted hedge fund manager Martin Shkreli and the fate of the Wu-Tang Clan's double-album
    Beltway Confidential

    U-God of Wu-Tang Clan: Martin Shkreli is a ‘cocky motherf—ker’

    Siraj Hashmi -
    March 9, 2018 6:40 pm
    0
    President Trump is expected to announce a 25 percent tariff on steel and a 10 percent tariff on aluminum this week. (AP Photo/Evan Vucci)
    Beltway Confidential

    Republicans will let tariffs ruin the economy, because they are afraid of angering Trump

    Philip Wegmann -
    March 8, 2018 6:46 pm
    0
    Express Scripts is one of the biggest pharmacy benefit managers in the country. (AP Photo/Jeff Roberson)
    Economy

    Cigna makes bid to buy drug plan middle man Express Scripts

    Robert King -
    March 8, 2018 12:46 pm
    0
    The two largest providers of prescription medication programs have nearly tripled the number of medications that insurance companies will no longer cover, according to a new study by the Doctor-Patient Rights Project. (AP Photo/Rich Pedroncelli, File)
    Healthcare

    Insurers’ exclusion of disease treatments increases costs

    Seth Ginsberg -
    March 8, 2018 5:01 am
    0
    Supporters of two Obamacare stabilization bills are looking into adding protections that prevent the money from funding abortions into a must-pass, two-year spending bill Congress is expected to take up this month. House Energy and Commerce Committee Chairman Rep. Greg Walden, R-Ore., said,
    Beltway Confidential

    House Republicans seek anti-abortion protections in Obamacare stabilization bills

    Robert King -
    March 8, 2018 12:27 am
    0
    The Right to Try Act allows terminally ill patients who have exhausted all other options to try medications that have passed basic Food and Drug Administration safety protocols but not completed the full, multiyear approval process. Such legislation has received overwhelming support nationally, becoming law in 38 states. (AP Photo/Rick Bowmer)
    Healthcare

    Andy Biggs and Brian Fitzpatrick: America needs the Right to Try, before it’s too late

    Andy Biggs, brian-fitzpatrick -
    March 7, 2018 9:56 pm
    0
    1...969798...159Page 97 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.